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Abstract 
mRNA profiling is a promising new method for the identification of body fluids 
from biological stains. In this study we aimed to establish a multiplex RT-PCR 
protocol for the detection and differentiation of sperm and seminal plasma. The 
Agilent Bioanalyzer and Nanodrop spectrophotometer were shown not to be 
suitable for assessing RNA quality and quantity of forensic stains. Semen 
specificity of the mRNA markers was successfully confirmed with singleplex 
PCR. Our data indicated that semen samples down to 0.1 µl and up to 20-year-
old could be identified with mRNA profiling. With the semen multiplex, including 2 
sperm markers (PRM1, PRM2) and 2 novel seminal plasma markers (SEMG1, 
PSA), samples from azoospermic men (absence of sperm in semen) are clearly 
distinguishable from those of normozoospermic men (having a normal sperm 
production). We think that our multiplex RT-PCR protocol is a reliable and 
sensitive method for the identification of semen in forensic samples. 
 
 
 
Key words 
Forensic science, mRNA, semen, PRM1, PRM2, SEMG1, PSA 
 3/8 
1. Introduction 
Currently, the identification of semen is sample- and time-consuming due to the 
requirement of separate presumptive tests for sperm and seminal plasma, both 
of them being necessary to identify azoospermic men. We recently showed that 
multiplex reverse transcription-polymerase chain reaction (RT-PCR) is a suitable 
tool to profile mRNA of several body fluids from biological stains [1]. In the 
present study we thus aimed to establish a multiplex RT-PCR protocol for the 
concurrent and sensitive detection of sperm and seminal plasma markers. The 
following genes were analyzed: protamine 1 and 2 (PRM1, PRM2) for the 
identification of sperm; semenogelin 1 (SEMG1) and prostate specific antigen 
(PSA) for the identification of seminal plasma. 
 
2. Materials and methods 
Samples: Semen from 6 normozoospermic and 1 azoospermic men and blood, 
saliva, buccal swabs, vaginal swabs, menstrual blood swabs from 2-3 different 
individuals were collected on cotton swabs and dried at room temperature (10-50 
µl body fluid or 5 µl of a semen dilution series). The human squamous carcinoma 
cell line UMB-SCC-745 was cultured under standard conditions and served as 
control. RNA-extraction, reverse transcription, endpoint PCR were described 
previously [1]. RNA quality and quantity were assessed with an Agilent 2100 
Bioanalyzer using a RNA pico chip (Agilent, Basel, Switzerland) and a Nanodrop 
1000 spectrophotometer (Witec, Littau, Switzerland), respectively. Primers for 
PRM1 and PRM2 were adopted from the literature [2], primers for SEMG1 and 
 4/8 
PSA were designed using the online softwares Primer3 and Roche Applied 
Science-Universal Probe library (SEMG1 forward: 5’-FAM-
TCGGTAACCATGTGAAAGGA, reverse: 5’-GTGTCATCCATGGACCAAGA, 
PSA forward: 5’-NED-TGTCCGTGACGTGGATTG, reverse: 5’-
GGTTGGGAATGCTTCTCG). Amplicon sizes are 82 bp for PSA, 120 bp for 
SEMG1, 153 bp for PRM1 and 294 bp for PRM2. Enzymatic/immunologic tests 
included acid phosphatase test (standard protocol), RSID semen test (Galantos 
Genetics, Mainz, Germany) and PSA Semiquant (Seratec, Göttingen, Germany). 
 
3. Results and discussion 
The quantity of the extracted RNA was below the detection limit of the Nanodrop 
spectrophotometer. The Agilent Bioanalyzer uses the RNA Integrity Number 
(RIN) for quality assessment, which takes not only the ratio of the 18S to 28S 
ribosomal subunits into account but the entire electrophoretic trace. The RIN 
classification is based on a numbering system with 1 being the most degraded 
profile and 10 the most intact. The RNA quality of the human cancer cell line 
UMB-SSC-745 was good with RIN 9.4, the RNA quality of the semen samples 
was poor, showing complete RNA degradation (RIN n/a). Nevertheless, after 
reverse transcription and marker-specific amplification, electropherograms 
reliably showed fragments of the expected sizes (Fig. 1). We therefore conclude 
that the Nanodrop Spectrophotometer and the Agilent Bioanalyzer are not 
suitable for assessing RNA quality and quantity of forensic samples. 
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Semen specificity of all mRNA markers was successfully confirmed with 
singleplex PCR, in that mRNA for the candidate genes were present in the 
semen samples but absent in all others. All RT minus controls (RT reaction 
without reverse transcriptase) were negative. Also high input amounts of 
genomic DNA (50 ng) didn’t show extraneous peaks at marker specific positions. 
The sensitivity of the assays was tested with semen dilution series on cotton 
swabs (5, 1, 0.5, 0.1, 0.05, 0.01 µl semen) from 5 different individuals. Our 
singleplex data indicated that semen samples down to 0.1 µl could be identified 
with mRNA profiling, slightly inferior to conventional enzymatic/immunologic 
tests, which identified semen down to 0.05 µl (Table 1). However, the achieved 
sensitivity of the mRNA method is suitable for forensic stains. 
With the semen multiplex, including the 2 markers for sperm cells (PRM1, PRM2) 
and the 2 markers for seminal fluid (SEMG1, PSA), samples from azoospermic 
men can clearly be distinguished from those of normozoospermic men (Fig. 1). 
The semen samples used in this study were up to 20-year-old, revealing as good 
results as fresh semen samples. 
 
4. Conclusion 
Although the RNA quality of forensic samples is poor, mRNA profiling proved to 
be a reliable and sensitive method for the identification of semen. Major 
advantages of mRNA profiling are the possibility to co-extract DNA from the 
same piece of stain and to analyze a whole set of body fluid specific markers in a 
multiplex PCR reaction. We believe that mRNA profiling will be the body fluid 
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identification method of the future, replacing sample- and time-consuming 
presumptive tests. 
 
References 
[1] Haas C, Klesser B, Maake C, Bär W, Kratzer A. mRNA profiling for body fluid 
identification by reverse transcription endpoint PCR and realtime PCR. Forensic 
Sci Int Genet. 3/2 (2009) 80-88. 
 
[2] Juusola J, and Ballantyne J. Multiplex mRNA profiling for the identification of 
body fluids. Forensic Sci Int 152 (2005) 1-12. 
 
 
Role of Funding 
no sponsors 
 
Acknowledgements 
The authors thank T. Lehmann for technical assistance. 
 
Conflict of interest 
none 
 
 
 
 
 7/8 
 
 
 
 
 
 
 
 
Table 1: Sensitivity of the mRNA profiling method compared to conventional 
enzymatic/immunologic tests. Semen dilution series of 5 different individuals were analyzed with 
the acid phosphatase test, the RSID semen test, the PSA semiquant test and mRNA profiling 
(singleplex PCR). The dark-colored squares represent 100% positive results, the light-colored 
squares represent positive results that were obtained only in 2-4 out of 5 samples, white squares 
represent 0-1 positive results out of 5 samples. 
 
 
 
 
 
 
 
 
 
 
 
 
 1 0.5 0.1 0.05 0.01   µl Semen 
Acid phosphatase test       
SEMG1 RSID test       
PSA Semiquant       
PRM1 RNA       
PRM2 RNA       
PSA RNA       
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Fig. 1: Multiplex PCR of a semen sample from a normozoospermic man (a) and 
an azoospermic man (b). The sperm-specific markers PRM1 and PRM2 are 
missing in sample b. 
 
 
